Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dabholkar

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Oncology Reports|May 21, 2011
Expression of an alternatively spliced ercc1 messenger-RNA species, is related to reduced DNA-repair efficiency in human T-lymphocytesM Dabholkar, J Vionnet, R Parker, et al.
Molecular Pharmacology|June 1, 1995
Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II)M N Benchekroun, R Parker, M Dabholkar, et al.
The Journal of Clinical Investigation|August 1, 1994
Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapyM Dabholkar, J Vionnet, F Bostick-Bruton, et al.
International Journal of Molecular Medicine|December 16, 1998
Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell linesJ J Yu, C Mu, M Dabholkar, et al.
Mutation Research|January 1, 1993
Expression of excision repair genes in non-malignant bone marrow from cancer patientsM Dabholkar, F Bostick-Bruton, C Weber, et al.
Journal of the National Cancer Institute|October 7, 1992
ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patientsM Dabholkar, F Bostick-Bruton, C Weber, et al.
Biochemical Pharmacology|November 15, 2000
Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissuesM Dabholkar, K Thornton, J Vionnet, et al.
International Journal of Oncology|May 6, 2011
Platinum-sensitive and platinum-resistant ovarian cancer tissues show differences in the relationships between mRNA levels of p53, ERCC1 and XPAJ Yu, M Dabholkar, W Bennett, et al.
Oncology Reports|August 19, 2000
Evidence for in the appearance of mRNAs of nucleotide excision repair genes, in human ovarian cancer tissuesE Reed, M Dabholkar, K Thornton, et al.
Journal of Postgraduate Medicine|January 1, 1985
Incidence of gonorrhoea in leucorrhoea casesM A Deshmukh, A P Mehta, K M Dabholkar, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Oncology Reports|May 21, 2011
Expression of an alternatively spliced ercc1 messenger-RNA species, is related to reduced DNA-repair efficiency in human T-lymphocytesM Dabholkar, J Vionnet, R Parker, et al.
Molecular Pharmacology|June 1, 1995
Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II)M N Benchekroun, R Parker, M Dabholkar, et al.
The Journal of Clinical Investigation|August 1, 1994
Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapyM Dabholkar, J Vionnet, F Bostick-Bruton, et al.
International Journal of Molecular Medicine|December 16, 1998
Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell linesJ J Yu, C Mu, M Dabholkar, et al.
Mutation Research|January 1, 1993
Expression of excision repair genes in non-malignant bone marrow from cancer patientsM Dabholkar, F Bostick-Bruton, C Weber, et al.
Journal of the National Cancer Institute|October 7, 1992
ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patientsM Dabholkar, F Bostick-Bruton, C Weber, et al.
Biochemical Pharmacology|November 15, 2000
Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissuesM Dabholkar, K Thornton, J Vionnet, et al.
International Journal of Oncology|May 6, 2011
Platinum-sensitive and platinum-resistant ovarian cancer tissues show differences in the relationships between mRNA levels of p53, ERCC1 and XPAJ Yu, M Dabholkar, W Bennett, et al.
Oncology Reports|August 19, 2000
Evidence for in the appearance of mRNAs of nucleotide excision repair genes, in human ovarian cancer tissuesE Reed, M Dabholkar, K Thornton, et al.
Journal of Postgraduate Medicine|January 1, 1985
Incidence of gonorrhoea in leucorrhoea casesM A Deshmukh, A P Mehta, K M Dabholkar, et al.
Pageof 3